Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Po-Hao Feng

Showing results (91-100 of 94) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 94 results.
Therapeutic Advances in Respiratory Disease|January 20, 2025
A real-world study to evaluate effectiveness of mepolizumab in treating severe asthma in Taiwan (REMIT)Shih-Lung Cheng, Shu-Min Lin, Chung-Kan Peng, et al.
Infectious Diseases and Therapy|May 21, 2024
A Phase 3, Randomized, Controlled Trial Evaluating the Efficacy and Safety of Ropeginterferon Alfa-2b in Patients with Moderate COVID-19Wang-Da Liu, Po-Hao Feng, Chien-Yu Cheng, et al.
Journal of Multidisciplinary Healthcare|January 28, 2025
Utilizing a Wireless Radar Framework in Combination With Deep Learning Approaches to Evaluate Obstructive Sleep Apnea Severity in Home-Setting EnvironmentsKun-Ta Lee, Wen-Te Liu, Yi-Chih Lin, et al.
Environmental Science and Pollution Research International|August 27, 2021
Associations between lung-deposited dose of particulate matter and culture-positive pulmonary tuberculosis pleurisyKuan-Jen Bai, Nguyen Thanh Tung, Ta-Chih Hsiao, et al.
Pageof 10

Showing results (91-100 of 94) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 94 results.
Therapeutic Advances in Respiratory Disease|January 20, 2025
A real-world study to evaluate effectiveness of mepolizumab in treating severe asthma in Taiwan (REMIT)Shih-Lung Cheng, Shu-Min Lin, Chung-Kan Peng, et al.
Infectious Diseases and Therapy|May 21, 2024
A Phase 3, Randomized, Controlled Trial Evaluating the Efficacy and Safety of Ropeginterferon Alfa-2b in Patients with Moderate COVID-19Wang-Da Liu, Po-Hao Feng, Chien-Yu Cheng, et al.
Journal of Multidisciplinary Healthcare|January 28, 2025
Utilizing a Wireless Radar Framework in Combination With Deep Learning Approaches to Evaluate Obstructive Sleep Apnea Severity in Home-Setting EnvironmentsKun-Ta Lee, Wen-Te Liu, Yi-Chih Lin, et al.
Environmental Science and Pollution Research International|August 27, 2021
Associations between lung-deposited dose of particulate matter and culture-positive pulmonary tuberculosis pleurisyKuan-Jen Bai, Nguyen Thanh Tung, Ta-Chih Hsiao, et al.
Pageof 10